Can an ultrasound predict falls in diabetic patients?
NCT ID NCT06778005
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study uses ultrasound to measure the size and appearance of leg nerves in people with type 2 diabetes who have nerve damage (diabetic polyneuropathy). Researchers will then test how these nerve measurements relate to balance, walking, and daily life. The goal is to better understand the link between nerve structure and physical function, which could help improve care for those at risk of falls.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better understand how nerve damage affects balance and walking in people with diabetes, potentially guiding future treatments.
- What could go wrong
- This is an observational study, not a treatment trial. It is small (86 people) and only looks at links, not causes. Results may not apply to everyone with diabetic neuropathy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 86 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2025
- Expected to finish
-
Nov 2025
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with diabetic polyneuropathy and healthy volunteers aged between 18-65 years old will be evaluated visiting our physical medicine and rehabilitation outpatient clinic between December 2024 and May 2025.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria (Group 1): * Being between the ages of 18-65 * Being literate * Signed a voluntary consent form agreeing to participate in the study Inclusion Criteria (Group 2): * Diagnosed with Type 2 Diabetes based on at least one of the following diagnostic criteria: fasting plasma glucose ≥ 126 mg/dl, 2-hour plasma glucose ≥ 200 mg/dl in an oral glucose tolerance test, HbA1c ≥ 6.5%, or diabetes symptoms (excessive thirst, eating, urination, and weight loss) + random plasma glucose ≥ 200 mg/dl. (14) * Diagnosed with diabetic peripheral polyneuropathy through EMG evaluation in addition to Type 2 Diabetes. * Being between the ages of 18-65 * Being literate * Signed a voluntary consent form agreeing to participate in the study. Exclusion Criteria: * Individuals under 18 years old and over 65 years old * Diagnosed with Type 1 diabetes * Use of medications that can cause polyneuropathy * Other causes of neuropathic pain (lumbar radiculopathy, spinal stenosis, -hereditary, inflammatory, entrapment neuropathies) * Undergoing lower extremity surgery (spine/hip/knee/foot) in the last 6 months * Having peripheral artery disease * B12 vitamin deficiency * Active foot ulcer * History of lower extremity amputation * Severe cardiopulmonary insufficiency (stage 3-4) * History of myocardial infarction within the last 1 month * History of unstable angina * Active systemic inflammatory diseases and active malignancy * Presence of vestibular disorders * Presence of cognitive impairment * Osteoarthritis in the lower extremity * Pregnancy * Body Mass Index (BMI) of 30 or higher
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabetes are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Sultan 2. Abdulhamid Han Training and Research Hospital
ACTIVE_NOT_RECRUITINGIstanbul, Üsküdar, 34674, Turkey (Türkiye)
-
Sultan 2. Abdulhamid Han Training and Research Hospital
RECRUITINGIstanbul, Üsküdar, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can mindfulness and yoga rewire diabetes habits?
- New pill takes aim at blood sugar in diabetes
- Home c-peptide tests could reveal hidden insulin production in diabetes
- Can a vegan diet delivered online help people with type 2 diabetes?
- Brain scans may predict who is most at risk for dangerous low blood sugar
- Diabetes devices put to the test: can home monitors match lab accuracy?